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ABSTRACT 
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Research Advisor: Dr. Jennifer L. Doleac 
Department of Economics 
Texas A&M University 
 
 
In 2010, the Affordable Care Act (ACA) was signed into effect by former President 
Barack Obama. The act had the intention of expanding Medicaid and making healthcare more 
affordable and accessible for Americans by drastically overhauling previous U.S. healthcare 
regulation. Although the magnitude of the changes proposed by the ACA were one-of-a-kind, the 
concept of healthcare expansion was not unique to the ACA. Back in 2001, the Bush 
Administration gave states the ability to expand healthcare coverage on their own terms through 
the Health Insurance Flexibility and Accountability (HIFA) Demonstrative Initiative. The 
initiative allowed states to pay for their healthcare expansion by rolling back healthcare package 
benefits and increasing sharing costs. Using HIFA waivers, a total of four states implemented 
programs that expanded coverage to additional substance use disorder (SUD) susceptible 
populations. With this change, more people in these states now had health care coverage, which 
meant that in theory, more people had access to mental and behavioral health services.  
To determine whether these HIFA waivers have caused a significant change in the 
treatment rates for people with SUDs, estimates for states with HIFA waivers were compared to 
states without said waivers. These estimates were tracked from 2001 to 2008 through a fixed-
effects model to determine whether there was a marked long-term difference associated with 
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healthcare expansion through HIFA. According to these figures, there is evidence to suggest that 
the Bush Administration’s HIFA waivers had mixed effects on SUD treatment numbers 
depending on the admission type.  
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NOMENCLATURE 
 
ACA  Affordable Care Act 
FPL  Federal Poverty Level 
HIFA  Health Insurance Flexibility and Accountability 
(S)CHIP (State) Children’s Health Insurance Program  
SUD  Substance Use Disorder 
TEDS  Treatment Episode Data Set 
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CHAPTER I 
INTRODUCTION 
 
The National Institute on Drug Abuse defines drug addiction as a mental illness that often 
co-occurs with other mental disorders (NIDA 2010). In the case of alcohol abuse, addiction and 
externalizing mental disorders such as oppositional-defiant disorder and conduct disorder are 
strongly associated with one another, producing additional challenges for treatment (Kessler 
2004). Studies have also shown that comorbid disorders are more chronic than isolated disorders, 
as those with a dual diagnosis often report a more severe and persistent history with mental 
issues and/or substance abuse.  
Despite the clinical severity of said comorbidity, the US legal system punishes the misuse 
of drugs/illicit substance with legal consequences (Miller & Spratt 2010). Instead of treating drug 
addicts as sufferers of debilitating mental illnesses, they are often treated as criminals engaging 
in willful misconduct. Drug addiction remains undifferentiated from substance abuse and is often 
treated wholly as a social issue than a mental one. To put things into perspective, for every dollar 
spent on drug abuse, 95% goes towards funding the legal punishments, compared to the 2% that 
pays for prevention and treatment (Larsen 2014.)  
In recent times, steps have been taken to expand the availability of substance use disorder 
(SUD) treatment1. In 2010, the ACA was signed into place by former President Barack Obama, 
defining “mental health and substance use disorder services” as an essential health benefit 
(Center for Consumer Information and Insurance Oversight 2011). By law, health insurance 
                                                 
1 From this point onward, drug addiction/abuse will be referred to as a “substance use disorder”.  
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providers were now required to cover said services in the hopes of expanding the nationwide 
availability of behavioral health resources.  
However, this is not the first time that a president has attempted to expand healthcare 
coverage to accommodate those with mental illnesses. In 2002, former President George W. 
Bush created the New Freedom Commission on Mental Health (NFCMH) to come up with 
healthcare recommendations that would improve the lives of those with serious mental illness 
and/or emotional disturbances (NFCMH 2003). In the commission’s report to the president, they 
stated that the current mental healthcare system was “fragmented, disconnected, and often 
inadequate.” The commission believed that a fundamental transformation to the existing system 
was necessary to connect Americans to the appropriate resources they need to treat their mental 
health illnesses.   
To make this change possible, the President’s New Freedom Initiative rolled out a new 
HIFA waiver option (NASUAD 2005). Under Section 1115 of the Social Security Act, states 
could implement new healthcare programs to cover individuals who are traditionally not covered 
by Medicaid. In general, the most vulnerable populations are covered under Medicaid, such as 
low-income families with dependents and pregnant women under a certain FPL (Wen et al. 
2017). By using HIFA waivers, states could expand Medicaid coverage to those who fell outside 
these categories.  
Although considered a vulnerable population by some, people with SUDs are often 
ineligible for Medicaid (Wen et al. 2017). Individuals with SUDs are more likely to be 
unemployed or in part-time job with low wages. As a result, these people cannot receive health 
care plans meant for full-time employees and often lack the income to afford coverage through 
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the private healthcare market. Due to this all-too-familiar scenario, those with SUDs are often 
overrepresented in the uninsured population and go untreated.  
HIFA attempted to bridge this treatment gap by covering more individuals who were 
beneath the FPL but were not traditionally covered under Medicaid. In theory, by allowing for 
flexibility in Medicaid/SCHIP eligibility requirements, more individuals with SUDs could get 
insured and subsequently seek out treatment. However, an empirical policy analysis is required 
to figure out whether HIFA was successful in achieving its goal.   
 
  
9 
CHAPTER II 
BACKGROUND 
 
The Health Insurance Flexibility and Accountability (HIFA) Demonstrative Initiative was 
introduced in August 4, 2001 as another type of Section 1115 waiver (Ryan 2002). Enacted 
during the Bush Administration, HIFA sought to increase healthcare coverage amongst the 
uninsured by making healthcare more accessible and affordable. These waivers States were 
given the authority to modify Medicaid and State Children’s Health Insurance Program (SCHIP) 
eligibility requirements so they could include childless adults and other populations that were not 
typically covered under these programs (Atherly et al. 2012). To assist those who still did not 
qualify for public health insurance after the eligibility expansions, HIFA also allowed individuals 
with incomes under 200% of the FPL to receive public subsidies for private health insurance 
premiums.   
As a Section 1115 waiver, HIFA waivers were required to be budget neutral to prevent 
increased federal government spending (Artiga 2009). As such, states had a few options in how 
they funded their HIFA waiver-based expansions. With the initial passage of the HIFA 
Demonstrative Initiative, States were also authorized to use unspent SCHIP funds to expand 
healthcare to different categories of adults, including childless adults (Baumrucker 2008). 
However, when the Deficit Reduction Act of 2005 was enacted, states could no longer create 
new waivers that would pay for the coverage for childless adults using unused SCHIP funds. 
From that point forward, states could now only pay for HIFA waiver expansions by imposing 
enrollment caps, providing different benefit packages for different eligible populations, and 
increasing cost-sharing charges (Coughlin and Zuckerman 2008).   
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Since the introduction of the HIFA Demonstrative Initiative in 2001, 14 states have 
implemented HIFA waiver-based program healthcare expansions (Atherly et al. 2012). These 
programs ran from 2001 to 2014, with Arizona being the first state to expand healthcare 
coverage through a HIFA waiver and New Mexico being the last state to have their waiver 
expire. The nature of these HIFA waiver programs vary wildly from state to state, with certain 
states only targeting one specific population (such as pregnant women or disabled working 
adults) while others expand eligibility to broader categories (NASUAD 2002). However, despite 
the differences between each state’s HIFA waiver program, one thing is certain: all of them 
succeeded in expanding coverage to previously uninsured individuals.  
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CHAPTER III 
DATA 
 
Dependent Variable: SUD Admission Rate 
State-level SUD admission numbers from Treatment Episode Data Set (TEDS) were used 
to quantify the impact of HIFA waiver expansion programs. To determine whether the impact 
was the same for treatments related to different drugs/illicit substances, admissions for alcohol, 
marijuana, heroin, cocaine, amphetamines (including meth), and non-heroin opiates/synthetics 
were evaluated separately in addition to total admission numbers. Furthermore, to account for the 
difference in population between states, admission numbers were converted into rates, per 
100,000 population.   
Independent Variable: “HIFA State” 
Between 2001 and 2008, a total of 15 states received approval for HIFA waivers (Wen et 
al. 2017). However, for the purposes of analyzing the effect of HIFA waiver expansions on SUD 
treatment, not all of these states are relevant. When determining the effects of HIFA waivers on 
SUD treatment, only a select number of states count as “HIFA states”. In this paper, the 
following states are considered HIFA states: Arizona, Illinois, Maine, and New Mexico.  
Out of the 15 states who received HIFA waivers, only eight had expansion programs that 
were comprehensive enough to be analyzed thoroughly (Atherly et al. 2012). From these eight 
states, Michigan, Oregon, Colorado, and Oklahoma, were not chosen as HIFA states as they had 
policies that were not beneficial to individuals with SUDs (Wen et al. 2017). Michigan’s 
expansion program failed to include specialty SUD treatment for adults, while Oregon had to 
retract SUD benefits due to a fiscal crisis. On the other hand, Colorado and Oklahoma had 
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focused primarily on expanding healthcare to specialized populations (pregnant women and 
working disabled adults, respectively.)  
Therefore, for the purposes of this study, the only states that were counted as HIFA states 
were the ones that implemented long-term programs that affected this paper’s target population: 
individuals with SUDs. A basic overview of these states’ HIFA waiver programs can be seen in 
the table below.  
 
Table 1. “HIFA States” 
State Year(s) Targeted Populations 
Arizona 2001 – 2011 • Pregnant women 
• Childless Adults 
• Parents of Medicaid and SCHIP eligible children 
Illinois 2002 – 2007 • Childless adults 
• Children of low-income families 
• Parents of SCHIP eligible children 
Maine 2002 – 2013 • Childless adults 
New Mexico 2005 – 2014 • Childless working adults 
• Uninsured working parents of Medicaid and 
SCHIP eligible children 
 
Other Controls 
When testing to determine the effect of HIFA waivers on SUD admission rates, there are 
two sources of variability to keep in mind: time-invariant state heterogeneity and national trends 
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in SUD admission rates. Therefore, a state fixed effects variable was added to control for the 
inherent differences in SUD admissions between states, and a year fixed effects variable was 
added to account for the changes in national SUD admissions that occur with time.    
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CHAPTER VI 
RESULTS 
 
Fixed Effects Model 
To determine whether HIFA waivers caused a significant change in treatment rates for 
SUD, statewide admission rates were analyzed in a two-way fixed effects model. This model 
therefore estimates the within-state changes in admission rates, when HIFA waivers are adopted, 
controlling for national trends in SUD treatment. As mentioned in the previous chapter, Arizona, 
Illinois, Maine, and New Mexico were defined as “HIFA states” for the analysis. Admission 
numbers published by SAMHSA from their Treatment Episode Data Set (TEDS) were analyzed 
over a 14-year period from 1998 to 2012 to create the following model:  
0 1 ,/100 ( )s t s tAdmissions k HIFA=  + + +     
where the subscript s denotes state and t denotes year. To isolate and estimate the effect 
that HIFA waivers have on state SUD admissions, 𝜌𝑠 and 𝜏𝑡 were included in the model to 
control for state fixed effects and year fixed effects, respectively. β0 represents the number of 
SUD admissions a state has regardless of their HIFA status, while β1 represents the effect that an 
active HIFA waiver has on SUD admission rates. HIFAs,t is an indicator variable that is equal to 
1 when state s has an active HIFA waiver in year t. Otherwise, HIFAs,t is equal to 0. 
 This base model was used to estimate the main effect of HIFA waivers on the following 
SUD admission rates: alcohol, marijuana, heroin, cocaine, amphetamines (including meth), non-
heroin opiates/synthetics, and total. The main effect estimators were calculated using SUD 
admission rates from 44 states. Alabama, Alaska, Mississippi, Rhode Island, Tennessee, and 
West Virginia were excluded entirely from the model due to missing and/or incomplete data.  
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The following table describes the main effect estimator, standard error, and p-value 
associated with the effect of HIFA waivers on different types of admission rates.  
 
Table 2. Main Effect of HIFA Waiver on Admission Rate Type 
Admission Type 
Main Effect 
Estimator Std. Error p-Value 
Alcohol 150.3622** 30.8541 1.4057 x 10-6 
Marijuana 19.6208* 9.1225 0.0319 
Heroin 136.5632** 20.8413 1.2174 x 10-10 
Cocaine 25.8764** 7.0090 2.4285 x 10-4 
Amphetamines 111.6387** 16.6483 4.6296 x 10-11 
Non-heroin 
opiates/synthetics -45.2675** 10.4206 1.6419 x 10-5 
Total 346.6155** 47.7668 1.2327 x 10-12 
Note: The following subscripts indicate statistical significance at certain levels of significance: 
** indicates statistical significance for α = 0.01 
*  indicates statistical significance for α = 0.05.  
 
As seen in Table 2, HIFA waivers have a statistically significant effect on all admission 
types with a level of significance of 0.05. The exact magnitude and direction of said effect varies 
with admission type, but the results indicate that HIFA waivers have a positive effect on the 
majority of SUD treatment rates, excluding those related to treatment for non-heroin 
opiates/synthetics.  
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As indicated by the main effect estimators above, HIFA waivers are associated with an 
increase in treatment rates for six admission types: alcohol, marijuana, heroin, cocaine, 
amphetamines, and total admissions.  The main effect estimators for these admission types range 
from approximately 19 per 100,000 marijuana admissions to 346 per 100,000 total admissions. 
Therefore, the change in SUD admissions associated with the implementation of a HIFA waiver 
ranges from a 0.0196 percentage point (pp) increase to a 0.3466 pp increase for all admission 
types excluding non-heroin opiates/synthetics.  
On the other hand, the main effect estimator associated with non-heroin opiate/synthetic 
SUD admissions indicates that, on average, a state with an active HIFA waiver will experience a 
0.0453 pp decrease in non-heroin opiate/synthetic admissions. The existence of a negative main 
effect estimator indicates that HIFA does not always have a positive effect on admission rates. In 
fact, there is evidence to suggest that HIFA waivers have varying effects on SUD treatment rates 
based on the type of substance.   
To put these numbers into context, the table below shows the average treatment 
admission rates for each substance taken over a 14-year period.  
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Table 3.1. Average SUD Treatment Rates for Different Substances (1998-2012) 
Year Alcohol Marijuana Heroin Cocaine 
Amphet-
amines 
Non-heroin 
opiates/ 
synthetics Total 
1998 452.7955 113.3864 113.3864 94.3409 89.6591 8.9545 839.1364 
1999 445.5455 117.3182 130.8182 87.1818 86.8636 10.0682 831.5227 
2000 428.2500 123.9318 128.7955 84.5455 90.0000 13.2727 825.5909 
2001 412.8409 129.3182 111.6136 80.5455 88.6818 17.8636 830.0000 
2002 410.4545 133.2045 100.5227 82.5455 100.4318 21.0000 848.2955 
2003 391.4318 130.2045 104.1591 86.2955 113.4318 25.0455 831.9091 
2004 384.8636 132.1364 108.8182 86.3636 106.5455 30.2273 839.7273 
2005 396.5000 138.8864 112.1364 92.5227 118.0227 36.8864 881.7500 
2006 415.2955 140.4545 102.2727 96.6136 112.2046 44.4318 901.3864 
2007 429.2273 140.6364 113.4773 91.1591 105.5227 53.3864 907.0682 
2008 446.4545 153.4773 116.4545 81.6591 125.9318 65.5682 930.2045 
2009 440.6136 158.2045 124.7273 63.7273 110.0000 73.4091 919.0682 
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Table 3.2. Average SUD Treatment Rates for Different Substances (1998-2012) [cont.] 
Year Alcohol Marijuana Heroin Cocaine 
Amphet-
amines 
Non-heroin 
opiates/ 
synthetics Total 
2010 399.7727 150.2955 129.7045 50.6591 111.9546 80.5909 854.5000 
2011 383.1591 146.3636 134.8864 48.4318 103.3182 90.9091 850.0227 
2012 362.9091 136.3182 128.1818 40.6136 104.6364 87.4773 826.7273 
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The average SUD admission rates for different substance types across a 14-year timespan 
puts the main effect estimators into perspective. For example, the 150.3622 increase in alcohol 
admissions per 100,000 is a 33.68% to 41.43% increase when put into context. This range is 
derived from taking the highest and lowest admission rates for each admission type from Table 
3.1 and 3.2 and then dividing these values with the relevant main effect estimator from Table 2. 
Using this same convention, the other main effect estimators can be put into context as follows:  
• A 19.6208 increase in marijuana treatment admissions per 100,000 represents an 
increase between 12.40% and 17.30%.  
• A 136.5632 increase in heroin treatment admissions per 100,000 represents an 
increase between 101.24% and 135.85%.  
•  A 25.8764 increase in cocaine treatment admissions per 100,000 represents an 
increase between 26.78% and 63.71%.  
• A 111.6387 increase in amphetamine treatment admissions per 100,000 represents 
an increase between 88.65% and 128.52%.  
• A 45.2675 decrease in non-heroin opiate/synthetic treatment admissions per 
100,000 represents a decrease between 49.79% and 505.53%.  
• A 346.6155 increase in total treatment admissions per 100,000 represents an 
increase between 37.26% and 41.98%. 
Therefore, the estimated effects of HIFA waivers on SUD admissions rates are both statistically 
and contextually significant.   
Coefficient Plot  
Although the two-way fixed effects model established whether HIFA waivers had a 
substantial effect on SUD admission rates, it did not explain whether the effect of HIFA varied 
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throughout a program’s lifespan. Looking at the coefficient associated with the presence of an 
active HIFA waiver is not enough to determine whether the effectiveness of a HIFA waiver 
program decreases, stays constant, or increases over time.  
To determine whether the effect of HIFA waivers changed throughout the duration of its 
corresponding program, SUD admission rates were once again evaluated through a two-way 
fixed effects model. However, a new variable was added to the fixed effects model to measure 
the change in SUD admission rates for each subsequent year leading up to and after the initial 
implementation of a HIFA waiver expansion program. These coefficients captured the effect of 
HIFA waivers six years before their initial implementation to nine years after they had taken 
effect. A visualization of this year-by-year analysis can be seen in the figures below.  
 
Figure 1. Coefficient Plot for HIFA Implementation Year (Total Admission) 
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Based on the main effect estimator for total admissions from Table 2 in the previous 
subsection, there is evidence to suggest that the implementation of a HIFA waiver caused a 
significant increase in total SUD admissions. Figure 1 supports this claim as indicated by the 
overall increase in SUD admissions that occur after the initial year of HIFA implementation, 
which is denoted by the red dashed line. However, when broken down into individual years, the 
difference in year-by-year admission rates before and after HIFA waiver implementation is not 
as drastic as one may expect. A significant drop in SUD admission rates occurs four years before 
the implementation of HIFA waiver, which might explain the substantial increase in SUD 
admission rates associated with the overall presence of an active HIFA waiver.   
 
Figure 2. Coefficient Plot for HIFA Implementation Year (Marijuana Admissions)  
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Figure 3. Coefficient Plot for HIFA Implementation Year (Amphetamine Admission)  
 A similar occurrence happens in the coefficient plots for marijuana and amphetamine 
treatment admission rates. There is a significant drop in marijuana and amphetamine admissions 
at four and two years before HIFA implementation, respectively. Once a HIFA waiver is 
implemented, both types of admissions experience a somewhat drastic increase in treatment 
rates. According to Figure 2, there is a smaller but still positive increase in marijuana admissions 
per year, while Figure 3 shows that amphetamine admissions seem to stay constant once a HIFA 
waiver is in effect. Both figures provide evidence that HIFA waivers cause an almost immediate 
increase in admission rates when first implemented. However, the same plots show that the 
change in admission rates for subsequent years is much less drastic.  
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Figure 4. Coefficient Plot for HIFA Implementation Year (Alcohol Admissions)  
 On the other hand, the coefficient plot for alcohol admissions suggests that a different 
underlying variable might be responsible for the increase in SUD admission rates. The main 
effect estimator associated with alcohol admissions from Table 2 was positive, suggesting that 
HIFA waivers caused an increase in alcohol treatment admissions. Figure 4 does not contradict 
this claim but hints at the existence of an underlying phenomena due to the difference in 
admission trends before and after HIFA implementation. As indicated by Figure 4, there is a 
gradual increase in alcohol-related admissions leading up to a HIFA waiver’s initial 
implementation. Once said waiver is in effect, it seems that admission rates stay relatively 
constant, hovering around 50 to 100 admissions per 100,000 for the next eight years. The stark 
difference in pre- and post-implementation trends suggests that some other factor is at play.  
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Figure 5. Coefficient Plot for HIFA Implementation Year (Heroin Admissions) 
Figure 6. Coefficient Plot for HIFA Implementation Year (Cocaine Admissions) 
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According to Figure 5, heroin admissions experience a sizable drop five years before the 
implementation of HIFA, while Figure 6 shows that cocaine admissions experience a drop four 
years before HIFA is implemented. As indicated by the main effect estimators from Table 2, on 
average, heroin and cocaine admissions increase with the presence of an active HIFA waiver. 
However, when the effect of HIFA waiver programs are evaluated at individual years, the year-
by-year change in these SUD admissions before and after implementation is not as drastic. In 
fact, these plots indicate that the effect of HIFA on SUD admission rates is primarily influenced 
by short-term decrease in the years leading up to the start of a HIFA waiver program.   
 
Figure 7. Coefficient Plot for HIFA Implementation Year (Non-Heroin Opiate/Synthetics 
Admission)  
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 Similar to alcohol admissions, there is evidence to suggest that non-heroin 
opiate/synthetic admissions are influenced by more than just HIFA waivers. In Figure 7, there is 
a decreasing trend in admissions that occurs in the years leading up the implementation of a 
HIFA waiver. However, once a HIFA waiver is implemented, it appears as though the admission 
rates stay relatively constant until the seven-year mark. The difference in before and after 
admission rates could indicate the existence of an underlying variable that stabilizes admission 
rates after HIFA is implemented.   
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CHAPTER V 
DISCUSSION 
 
Since the main effect estimators associated with HIFA waivers were statistically 
significant for all admission types, there is evidence to suggest that the implementation of HIFA 
waivers influenced SUD admission rates. According to these same main effect estimators, HIFA 
waivers had a positive effect on the majority of admission rates, with the exception of non-heroin 
opiates/synthetics. The magnitude of these effects varies significantly, with the lowest being a 
12.40% to 17.30% increase in alcohol admissions to a 49.79% and 505.53% decrease in non-
heroin opiate/synthetic admissions.  
The negative main effect estimator associated with non-heroin opiate/synthetic 
admissions implies that HIFA waivers caused a decrease in the number of people seeking 
treatment for said substances. A possible reason for this occurrence may be an increased access 
to prescription opiates such as OxyContin and Vicodin (NIDA n.d.). By expanding healthcare 
coverage to previously uninsured individuals through HIFA, more people now had easier access 
to doctors who could prescribe opiates. It is possible that some individuals took this opportunity 
to abuse prescription opiates, which could lead to lower treatment rates. However, this is no 
more than an educated guess, as confirming this theory would require more in-depth research on 
whether the implementation of HIFA caused a significant increase in the number of non-heroin 
opiate prescriptions.  
As discussed previously, HIFA waivers were created as a potential solution to America’s 
inadequate mental health problem. With recommendation from the New Freedom Commission 
on Mental Health, the Bush administration created HIFA waivers to expand healthcare to more 
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people in hopes of improving the lives of those with serious mental illnesses and/or emotional 
disturbances, such as substance use disorder. HIFA has already been shown to have statistically 
significant large-scale effects, but to further increase the effectiveness of HIFA waivers and, by 
extension, other expansionary healthcare waivers, more research must be done.  
Making more populations eligible for public health insurance programs like Medicaid is 
one approach to expanding SUD treatment, but increasing public awareness of such initiatives 
and reducing the negative perception associated with treatment are other viable approaches. 
Using policy-based expansion to increase SUD treatment rates is insufficient on its own, since 
individuals could be unaware of such resources or may be hesitant in seeking treatment due to 
social/cultural stigma. Quantifying public awareness and perception is possible through surveys 
and online search engine queries. Advertising these programs and emphasizing the public 
benefits they produce may be influential in further increasing SUD treatment rates, which is the 
fundamental goal of expansionary policies like HIFA.  
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